Tongshu Gene
PrivateLast Round
Series D
Oct 8, 2024
Total Funding Raised
$91.83M
Company Overview
Tongshu Gene operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series D round in October 2024.
Tongshu Gene is a biotechnology company that develops diagnostic molecular pathology projects and ctDNA precision detection systems for tumor precision medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Telemedicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tongshu Gene Comparables
Compare Tongshu Gene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HaploX | 88% | |
| 求臻医学 | 88% | |
| Beijing Geneplus Technology | 88% |
For institutional investors. Book with your work email.
Tongshu Gene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 8, 2024 | ||||
| Series C | Jun 15, 2021 | ||||
| Series B | Sep 22, 2020 | ||||
| Angel | Nov 1, 2016 |
For institutional investors. Book with your work email.
Tongshu Gene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Haichuang FOF | Series C |
| GL Capital Group | Series C |
| YuanBio Venture Capital | Series B |
| Oceanpine Capital | Series C |
| Galaxy Yuanhui Investment Co., Ltd. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2024
$14M round raised
- Jun 15, 2021
$78M round led by GL Capital Group and Oceanpine Capital.
For institutional investors. Book with your work email.
Tongshu Gene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tongshu Gene's valuation, stock price, and market status.
Is Tongshu Gene a public or private company?
Tongshu Gene is a private company.
What is the current stock price of Tongshu Gene?
Tongshu Gene is a private company, so its shares have no public market price. Caplight tracks Tongshu Gene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tongshu Gene worth (valuation)?
Valuation information for Tongshu Gene is not publicly available.
Can I buy Tongshu Gene stock?
Tongshu Gene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tongshu Gene's last funding round?
Tongshu Gene's most recent funding round was Series D on October 8, 2024.
Who are the main investors in Tongshu Gene?
Key investors in Tongshu Gene include GL Capital Group, YuanBio Venture Capital, Oceanpine Capital.
Will Tongshu Gene IPO soon?
No public IPO plans have been announced for Tongshu Gene.
How can I track Tongshu Gene secondary market activity?
Caplight tracks bids, offers, and trades in Tongshu Gene's shares on secondary markets.